Literature DB >> 25187637

Characterization and multicentric validation of a common standard for Toxoplasma gondii detection using nucleic acid amplification assays.

Emmanuelle Varlet-Marie1, Yvon Sterkers2, Marie-Pierre Brenier-Pinchart3, Sophie Cassaing4, Frédéric Dalle5, Laurence Delhaes6, Denis Filisetti7, Hervé Pelloux3, Fériel Touafek8, Hélène Yera9, Patrick Bastien10.   

Abstract

The molecular diagnosis of toxoplasmosis essentially relies upon laboratory-developed methods and suffers from lack of standardization, hence the large diversity of performances between laboratories. Moreover, quantifications of parasitic loads differ among centers, a fact which prevents the possible prediction of the severity of this disease as a function of parasitic loads. The objectives of this multicentric study performed in eight proficient laboratories of the Molecular Biology Pole of the French National Reference Center for Toxoplasmosis (NRC-T) were (i) to assess the suitability of a lyophilized preparation of Toxoplasma gondii as a common standard for use in this PCR-based molecular diagnosis and (ii) to make this standard available to the community. High-quality written procedures were used for the production and qualification of this standard. Three independent batches of this standard, containing concentrations ranging from 10(4) to 0.01 T. gondii genome equivalents per PCR, were first assessed: the linear dynamic range was ≥ 6 log, the intra-assay coefficients of variation (CV) from a sample containing 10 T. gondii organisms per PCR were 0.3% to 0.42%, and the interassay CV over a 2-week period was 0.76% to 1.47%. A further assessment in eight diagnostic centers showed that the standard is stable, robust, and reliable. These lyophilized standards can easily be produced at a larger scale when needed and can be made widely available at the national level. To our knowledge, this is the first quality control assessment of a common standard which is usable both for self-evaluation in laboratories and for accurate quantification of parasitic loads in T. gondii prenatal infections.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25187637      PMCID: PMC4313224          DOI: 10.1128/JCM.01906-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR.

Authors:  W L Homan; M Vercammen; J De Braekeleer; H Verschueren
Journal:  Int J Parasitol       Date:  2000-01       Impact factor: 3.981

2.  Comparison of an industry-derived LCx Chlamydia pneumoniae PCR research kit to in-house assays performed in five laboratories.

Authors:  Max Chernesky; Marek Smieja; Julius Schachter; James Summersgill; Laura Schindler; Natalie Solomon; Karen Campbell; LeeAnn Campbell; Alison Cappuccio; Charlotte Gaydos; Sylvia Chong; Jeanne Moncada; Jack Phillips; Dan Jang; Billie Jo Wood; Astrid Petrich; Margaret Hammerschlag; Mike Cerney; James Mahony
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

3.  Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii.

Authors:  Stéphane Romand; Muriel Chosson; Jacqueline Franck; Martine Wallon; François Kieffer; Karine Kaiser; Henri Dumon; François Peyron; Philippe Thulliez; Stéphane Picot
Journal:  Am J Obstet Gynecol       Date:  2004-03       Impact factor: 8.661

4.  Comparison of two widely used PCR primer systems for detection of toxoplasma in amniotic fluid, blood, and tissues.

Authors:  Elisabeth Chabbert; Laurence Lachaud; Lucien Crobu; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

5.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

6.  Novel interpretation of molecular diagnosis of congenital toxoplasmosis according to gestational age at the time of maternal infection.

Authors:  Yvon Sterkers; Francine Pratlong; Sahar Albaba; Julie Loubersac; Marie-Christine Picot; Vanessa Pretet; Eric Issert; Pierre Boulot; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

7.  Comparison of six PCR methods using peripheral blood for detection of canine visceral leishmaniasis.

Authors:  Laurence Lachaud; Sarah Marchergui-Hammami; Elisabeth Chabbert; Jacques Dereure; Jean Pierre Dedet; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 8.  Molecular diagnosis of toxoplasmosis.

Authors:  Patrick Bastien
Journal:  Trans R Soc Trop Med Hyg       Date:  2002-04       Impact factor: 2.184

9.  Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings.

Authors:  Daniel Ajzenberg; Nadine Cogné; Luc Paris; Marie-Hélène Bessières; Philippe Thulliez; Denis Filisetti; Hervé Pelloux; Pierre Marty; Marie-Laure Dardé
Journal:  J Infect Dis       Date:  2002-08-05       Impact factor: 5.226

10.  Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes.

Authors:  Udo Reischl; Stéphane Bretagne; Dominique Krüger; Pauline Ernault; Jean-Marc Costa
Journal:  BMC Infect Dis       Date:  2003-05-02       Impact factor: 3.090

View more
  4 in total

1.  Evaluation of Toxoplasma ELITe MGB Real-Time PCR Assay for Diagnosis of Toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Pierre Brenier-Pinchart; Hélène Yera; Sorya Belaz; Emmanuelle Varlet-Marie; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2017-02-15       Impact factor: 5.948

2.  Inhibition of polymerase chain reaction: Pathogen-specific controls are better than human gene amplification.

Authors:  Guillaume Roux; Christophe Ravel; Emmanuelle Varlet-Marie; Rachel Jendrowiak; Patrick Bastien; Yvon Sterkers
Journal:  PLoS One       Date:  2019-09-27       Impact factor: 3.240

3.  Impact of pre-analytic step duration on molecular diagnosis of toxoplasmosis for five types of biological samples.

Authors:  Marie-Pierre Brenier-Pinchart; Emmanuelle Varlet-Marie; Florence Robert-Gangneux; Denis Filisetti; Juliette Guitard; Yvon Sterkers; Hélène Yera; Hervé Pelloux; Patrick Bastien
Journal:  PLoS One       Date:  2021-02-17       Impact factor: 3.240

4.  Comparison of the Performances of Five Primer Sets for the Detection and Quantification of Plasmodium in Anopheline Vectors by Real-Time PCR.

Authors:  V Chaumeau; C Andolina; B Fustec; N Tuikue Ndam; C Brengues; S Herder; D Cerqueira; T Chareonviriyaphap; F Nosten; V Corbel
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.